These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 21237607)

  • 1. Advances in validation, risk and uncertainty assessment of bioanalytical methods.
    Rozet E; Marini RD; Ziemons E; Boulanger B; Hubert P
    J Pharm Biomed Anal; 2011 Jun; 55(4):848-58. PubMed ID: 21237607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Key elements of bioanalytical method validation for small molecules.
    Bansal S; DeStefano A
    AAPS J; 2007 Mar; 9(1):E109-14. PubMed ID: 17408234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of immunoassay for protein biomarkers: bioanalytical study plan implementation to support pre-clinical and clinical studies.
    Valentin MA; Ma S; Zhao A; Legay F; Avrameas A
    J Pharm Biomed Anal; 2011 Jul; 55(5):869-77. PubMed ID: 21530130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capsule review on bioanalytical method transfer: opportunities and challenges for chromatographic methods.
    Lin ZJ; Li W; Weng N
    Bioanalysis; 2011 Jan; 3(1):57-66. PubMed ID: 21175367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the bioanalytical community ready to revise the use of certain validation concepts and nomenclature?
    Olsson AO; Liljeblad M; Nilsson LB; Silvester S
    Bioanalysis; 2012 Jul; 4(14):1705-8. PubMed ID: 22877214
    [No Abstract]   [Full Text] [Related]  

  • 6. Uncertainty profiles for the validation of analytical methods.
    Saffaj T; Ihssane B
    Talanta; 2011 Sep; 85(3):1535-42. PubMed ID: 21807219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Method validation and application of protein biomarkers: basic similarities and differences from biotherapeutics.
    Lee JW
    Bioanalysis; 2009 Nov; 1(8):1461-74. PubMed ID: 21083095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical review of near-infrared spectroscopic methods validations in pharmaceutical applications.
    De Bleye C; Chavez PF; Mantanus J; Marini R; Hubert P; Rozet E; Ziemons E
    J Pharm Biomed Anal; 2012 Oct; 69():125-32. PubMed ID: 22464561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new approach to evaluate regression models during validation of bioanalytical assays.
    Singtoroj T; Tarning J; Annerberg A; Ashton M; Bergqvist Y; White NJ; Lindegardh N; Day NP
    J Pharm Biomed Anal; 2006 Apr; 41(1):219-27. PubMed ID: 16332425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Issues in evaluation of bioanalytical method selectivity and drug stability.
    Dadgar D; Burnett PE
    J Pharm Biomed Anal; 1995 Dec; 14(1-2):23-31. PubMed ID: 8833963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development, validation and transfer of a near infrared method to determine in-line the end point of a fluidised drying process for commercial production batches of an approved oral solid dose pharmaceutical product.
    Peinado A; Hammond J; Scott A
    J Pharm Biomed Anal; 2011 Jan; 54(1):13-20. PubMed ID: 20801599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative assessment of bioanalytical method validation guidelines for pharmaceutical industry.
    Kadian N; Raju KS; Rashid M; Malik MY; Taneja I; Wahajuddin M
    J Pharm Biomed Anal; 2016 Jul; 126():83-97. PubMed ID: 27179186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do placebo based validation standards mimic real batch products behaviour? Case studies.
    Bouabidi A; Talbi M; Bouklouze A; El Karbane M; Bourichi H; El Guezzar M; Ziemons E; Hubert P; Rozet E
    J Pharm Biomed Anal; 2011 Jun; 55(3):583-90. PubMed ID: 21377822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory observations in bioanalytical determinations.
    Viswanathan CT
    Bioanalysis; 2010 Jul; 2(7):1325-9. PubMed ID: 21083243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of various international guidelines for analytical method validation.
    Chandran S; Singh RS
    Pharmazie; 2007 Jan; 62(1):4-14. PubMed ID: 17294806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioanalytical method validation: notable points in the 2009 draft EMA Guideline and differences with the 2001 FDA Guidance.
    Smith G
    Bioanalysis; 2010 May; 2(5):929-35. PubMed ID: 21083222
    [No Abstract]   [Full Text] [Related]  

  • 17. Aspects of bioanalytical method validation for the quantitative determination of trace elements.
    Levine KE; Tudan C; Grohse PM; Weber FX; Levine MA; Kim YS
    Bioanalysis; 2011 Aug; 3(15):1699-712. PubMed ID: 21827269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A strategy for a post-method-validation use of incurred biological samples for establishing the acceptability of a liquid chromatography/tandem mass-spectrometric method for quantitation of drugs in biological samples.
    Jemal M; Ouyang Z; Powell ML
    Rapid Commun Mass Spectrom; 2002; 16(16):1538-47. PubMed ID: 12203245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the quantitative performances and measurement uncertainty estimates obtained during method validation versus routine applications of a novel hydrophilic interaction chromatography method for the determination of cidofovir in human plasma.
    Lecomte F; Hubert C; Demarche S; De Bleye C; Dispas A; Jost M; Frankenne F; Ceccato A; Rozet E; Hubert P
    J Pharm Biomed Anal; 2012 Jan; 57():153-65. PubMed ID: 21959349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioanalytical considerations in the comparability assessment of biotherapeutics.
    Lee JW; Wang YM; Moxness M; DeSilva B
    Bioanalysis; 2011 Mar; 3(6):613-22. PubMed ID: 21417731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.